Sero Diagnostics Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 21-06-2024
- Paid Up Capital ₹ 1.00 M
as on 21-06-2024
- Company Age 38 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 85.80 M
as on 21-06-2024
- Revenue 26.71%
(FY 2022)
- Profit 170.07%
(FY 2022)
- Ebitda -5.34%
(FY 2022)
- Net Worth 1.58%
(FY 2022)
- Total Assets 2.12%
(FY 2022)
About Sero Diagnostics
The Company is engaged in the Real Estate Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company has closed loans amounting to ₹8.58 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Ravikant Garg and Dhanisha Garg serve as directors at the Company.
- CIN/LLPIN
U15143MH1985PTC038490
- Company No.
038490
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Dec 1985
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sero Diagnostics?
Board Members(2)
Financial Performance and Corporate Structure Insights of Sero Diagnostics.
Sero Diagnostics Pvt Ltd, for the financial year ended 2022, experienced significant growth in revenue, with a 26.71% increase. The company also saw a substantial improvement in profitability, with a 170.07% increase in profit. The company's net worth moved up by a moderate rise of 1.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sero Diagnostics?
In 2018, Sero Diagnostics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Shamrao Vithal Co-Operative Bank Ltd Creation Date: 26 Mar 2010 | ₹8.58 Cr | Satisfied |
How Many Employees Work at Sero Diagnostics?
Unlock and access historical data on people associated with Sero Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sero Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sero Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
